At a Glance
Editorial context: Verify the original source, publication date, scope and subsequent official updates before changing clinical or administrative practice. A draft or announcement is not necessarily a final rule.
On 13 October 2026, WHO announced a research toolkit addressing tuberculosis during pregnancy and lactation. The initiative focuses on improving research practice and evidence generation for people who are pregnant or breastfeeding.
Why this matters
TB in pregnancy requires timely diagnosis and appropriate treatment while considering maternal and infant outcomes. Historically, evidence gaps have complicated decisions about prevention, treatment and medicine safety in these groups.
Clinical relevance
- Healthcare teams should screen and evaluate suspected TB promptly under applicable national guidelines.
- Researchers can use the toolkit to plan more inclusive and consistent studies.
- This announcement is a research resource, not a new stand-alone prescription or replacement for Indian NTEP guidance.
India relevance and limitations
Maternal TB care is relevant to obstetric, pulmonary and public-health services in India. Specific treatment regimens must follow current NTEP and specialist recommendations; this article does not suggest new doses.
Official source
Medical information for professional awareness; not individual treatment advice.